This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hiebert, S. W.
Right arrow Articles by Cleveland, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hiebert, S. W.
Right arrow Articles by Cleveland, J. L.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 12 1995, 6864-6874, Vol 15, No. 12
Copyright © 1995, American Society for Microbiology

E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis

SW Hiebert, G Packham, DK Strom, R Haffner, M Oren, G Zambetti and JL Cleveland
Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

The E2F DNA binding activity consists of a heterodimer between E2F and DP family proteins, and these interactions are required for association of E2F proteins with pRb and the pRb-related proteins p107 and p130, which modulate E2F transcriptional activities. E2F-1 expression is sufficient to release fibroblasts from G0 and induce entry into S phase, yet it also initiates apoptosis. To investigate the mechanisms of E2F-induced apoptosis, we utilized interleukin-3 (IL-3)-dependent 32D.3 myeloid cells, a model of hematopoietic progenitor programmed cell death. In the absence of IL-3, E2F-1 alone was sufficient to induce apoptosis, and p53 levels were diminished. DP-1 alone was not sufficient to induce cell cycle progression or alter rates of death following IL-3 withdrawal. However, overexpression of both E2F-1 and DP- 1 led to the rapid death of cells even in the presence of survival factors. In the presence of IL-3, levels of endogenous wild-type p53 increased in response to E2F-1, and coexpression of DP-1 further augmented p53 levels. These results provide evidence that E2F is a functional link between the tumor suppressors p53 and pRb. However, induction of p53 alone was not sufficient to trigger apoptosis, suggesting that the ability of E2F to override survival factors involves additional effectors.


This article has been cited by other articles:

  • Liontos, M., Niforou, K., Velimezi, G., Vougas, K., Evangelou, K., Apostolopoulou, K., Vrtel, R., Damalas, A., Kontovazenitis, P., Kotsinas, A., Zoumpourlis, V., Tsangaris, G. Th., Kittas, C., Ginsberg, D., Halazonetis, T. D., Bartek, J., Gorgoulis, V. G. (2009). Modulation of the E2F1-Driven Cancer Cell Fate by the DNA Damage Response Machinery and Potential Novel E2F1 Targets in Osteosarcomas. Am. J. Pathol. 175: 376-391 [Abstract] [Full Text]  
  • Jenal, M., Trinh, E., Britschgi, C., Britschgi, A., Roh, V., Vorburger, S. A., Tobler, A., Leprince, D., Fey, M. F., Helin, K., Tschan, M. P. (2009). The Tumor Suppressor Gene Hypermethylated in Cancer 1 Is Transcriptionally Regulated by E2F1. Mol Cancer Res 7: 916-922 [Abstract] [Full Text]  
  • Udayakumar, T. S., Hachem, P., Ahmed, M. M., Agrawal, S., Pollack, A. (2008). Antisense MDM2 Enhances E2F1-Induced Apoptosis and the Combination Sensitizes Androgen-Dependent and Androgen-Independent Prostate Cancer Cells to Radiation. Mol Cancer Res 6: 1742-1754 [Abstract] [Full Text]  
  • Sharma, S. V., Settleman, J. (2007). Oncogene addiction: setting the stage for molecularly targeted cancer therapy. Genes Dev. 21: 3214-3231 [Abstract] [Full Text]  
  • Russo, A. J., Magro, P. G., Hu, Z., Li, W.-W., Peters, R., Mandola, J., Banerjee, D., Bertino, J. R. (2006). E2F-1 Overexpression in U2OS Cells Increases Cyclin B1 Levels and cdc2 Kinase Activity and Sensitizes Cells to Antimitotic Agents.. Cancer Res. 66: 7253-7260 [Abstract] [Full Text]  
  • Hashimoto, A., Hirose, K., Iino, M. (2005). BAD Detects Coincidence of G2/M Phase and Growth Factor Deprivation to Regulate Apoptosis. J. Biol. Chem. 280: 26225-26232 [Abstract] [Full Text]  
  • Ishida, H., Masuhiro, Y., Fukushima, A., Argueta, J. G. M., Yamaguchi, N., Shiota, S., Hanazawa, S. (2005). Identification and Characterization of Novel Isoforms of Human DP-1: DP-1{alpha} REGULATES THE TRANSCRIPTIONAL ACTIVITY OF E2F1 AS WELL AS CELL CYCLE PROGRESSION IN A DOMINANT-NEGATIVE MANNER. J. Biol. Chem. 280: 24642-24648 [Abstract] [Full Text]  
  • Li, Z., Stanelle, J., Leurs, C., Hanenberg, H., Putzer, B. M. (2005). Selection of novel mediators of E2F1-induced apoptosis through retroviral expression of an antisense cDNA library. Nucleic Acids Res 33: 2813-2821 [Abstract] [Full Text]  
  • IAQUINTA, P.J., ASLANIAN, A., LEES, J.A. (2005). Regulation of the Arf/p53 Tumor Surveillance Network by E2F. Cold Spring Harb Symp Quant Biol 70: 309-316 [Abstract]  
  • Rogoff, H. A., Pickering, M. T., Debatis, M. E., Jones, S., Kowalik, T. F. (2002). E2F1 Induces Phosphorylation of p53 That Is Coincident with p53 Accumulation and Apoptosis. Mol. Cell. Biol. 22: 5308-5318 [Abstract] [Full Text]  
  • Cloud, J. E., Rogers, C., Reza, T. L., Ziebold, U., Stone, J. R., Picard, M. H., Caron, A. M., Bronson, R. T., Lees, J. A. (2002). Mutant Mouse Models Reveal the Relative Roles of E2F1 and E2F3 In Vivo. Mol. Cell. Biol. 22: 2663-2672 [Abstract] [Full Text]  
  • Stanelle, J., Stiewe, T., Theseling, C. C., Peter, M., Putzer, B. M. (2002). Gene expression changes in response to E2F1 activation. Nucleic Acids Res 30: 1859-1867 [Abstract] [Full Text]  
  • Hauck, L., Kaba, R. G., Lipp, M., Dietz, R., von Harsdorf, R. (2002). Regulation of E2F1-Dependent Gene Transcription and Apoptosis by the ETS-Related Transcription Factor GABP{gamma}1. Mol. Cell. Biol. 22: 2147-2158 [Abstract] [Full Text]  
  • Fan, G., Ma, X., Kren, B. T., Steer, C. J. (2002). Unbound E2F modulates TGF-{beta}1-induced apoptosis in HuH-7 cells. J. Cell Sci. 115: 3181-3191 [Abstract] [Full Text]  
  • Elliott, M. J., Dong, Y. B., Yang, H., McMasters, K. M. (2001). E2F-1 Up-Regulates c-Myc and p14ARF and Induces Apoptosis in Colon Cancer Cells. Clin. Cancer Res. 7: 3590-3597 [Abstract] [Full Text]  
  • Amann, J. M., Nip, J., Strom, D. K., Lutterbach, B., Harada, H., Lenny, N., Downing, J. R., Meyers, S., Hiebert, S. W. (2001). ETO, a Target of t(8;21) in Acute Leukemia, Makes Distinct Contacts with Multiple Histone Deacetylases and Binds mSin3A through Its Oligomerization Domain. Mol. Cell. Biol. 21: 6470-6483 [Abstract] [Full Text]  
  • Morris, E. J., Keramaris, E., Rideout, H. J., Slack, R. S., Dyson, N. J., Stefanis, L., Park, D. S. (2001). Cyclin-Dependent Kinases and P53 Pathways Are Activated Independently and Mediate Bax Activation in Neurons after DNA Damage. J. Neurosci. 21: 5017-5026 [Abstract] [Full Text]  
  • Gala, S., Marreiros, A., Stewart, G. J., Williamson, P. (2001). Overexpression of E2F-1 leads to cytokine-independent proliferation and survival in the hematopoietic cell line BaF-B03. Blood 97: 227-234 [Abstract] [Full Text]  
  • Chen, Q., Hung, F.-C., Fromm, L., Overbeek, P. A. (2000). Induction of Cell Cycle Entry and Cell Death in Postmitotic Lens Fiber Cells by Overexpression of E2F1 or E2F2. IOVS 41: 4223-4231 [Abstract] [Full Text]  
  • Amanullah, A., Hoffman, B., Liebermann, D. A. (2000). Deregulated E2F-1 blocks terminal differentiation and loss of leukemogenicity of M1 myeloblastic leukemia cells without abrogating induction of p15INK4B and p16INK4A. Blood 96: 475-482 [Abstract] [Full Text]  
  • Flatt, P. M., Tang, L. J., Scatena, C. D., Szak, S. T., Pietenpol, J. A. (2000). p53 Regulation of G2 Checkpoint Is Retinoblastoma Protein Dependent. Mol. Cell. Biol. 20: 4210-4223 [Abstract] [Full Text]  
  • Park, D. S., Morris, E. J., Bremner, R., Keramaris, E., Padmanabhan, J., Rosenbaum, M., Shelanski, M. L., Geller, H. M., Greene, L. A. (2000). Involvement of Retinoblastoma Family Members and E2F/DP Complexes in the Death of Neurons Evoked by DNA Damage. J. Neurosci. 20: 3104-3114 [Abstract] [Full Text]  
  • Giovanni, A., Keramaris, E., Morris, E. J., Hou, S. T., O'Hare, M., Dyson, N., Robertson, G. S., Slack, R. S., Park, D. S. (2000). E2F1 Mediates Death of B-amyloid-treated Cortical Neurons in a Manner Independent of p53 and Dependent on Bax and Caspase 3. J. Biol. Chem. 275: 11553-11560 [Abstract] [Full Text]  
  • Yang, H. L., Dong, Y. B., Elliott, M. J., Liu, T. J., McMasters, K. M. (2000). Caspase Activation and Changes in Bcl-2 Family Member Protein Expression Associated with E2F-1-mediated Apoptosis in Human Esophageal Cancer Cells. Clin. Cancer Res. 6: 1579-1589 [Abstract] [Full Text]  
  • Schaley, J., O'Connor, R. J., Taylor, L. J., Bar-Sagi, D., Hearing, P. (2000). Induction of the Cellular E2F-1 Promoter by the Adenovirus E4-6/7 Protein. J. Virol. 74: 2084-2093 [Abstract] [Full Text]  
  • Strom, D. K., Nip, J., Westendorf, J. J., Linggi, B., Lutterbach, B., Downing, J. R., Lenny, N., Hiebert, S. W. (2000). Expression of the AML-1 Oncogene Shortens the G1 Phase of the Cell Cycle. J. Biol. Chem. 275: 3438-3445 [Abstract] [Full Text]  
  • García, I., Murga, M., Vicario, A., Field, S. J., Zubiaga, A. M. (2000). A Role for E2F1 in the Induction of Apoptosis during Thymic Negative Selection. Cell Growth Differ. 11: 91-98 [Abstract] [Full Text]  
  • Zhu, J. W., DeRyckere, D., Li, F. X., Wan, Y. Y., DeGregori, J. (1999). A Role for E2F1 in the Induction of ARF, p53, and Apoptosis during Thymic Negative Selection. Cell Growth Differ. 10: 829-838 [Abstract] [Full Text]  
  • Dai, H., Kramer, D. L., Yang, C., Murti, K. G., Porter, C. W., Cleveland, J. L. (1999). The Polyamine Oxidase Inhibitor MDL-72,527 Selectively Induces Apoptosis of Transformed Hematopoietic Cells through Lysosomotropic Effects. Cancer Res. 59: 4944-4954 [Abstract] [Full Text]  
  • Vigo, E., Muller, H., Prosperini, E., Hateboer, G., Cartwright, P., Moroni, M. C., Helin, K. (1999). CDC25A Phosphatase Is a Target of E2F and Is Required for Efficient E2F-Induced S Phase. Mol. Cell. Biol. 19: 6379-6395 [Abstract] [Full Text]  
  • Yang, H. L., Dong, Y. B., Elliott, M. J., Liu, T. J., Atienza, C. Jr., Stilwell, A., McMasters, K. M. (1999). Adenovirus-mediated E2F-1 Gene Transfer Inhibits MDM2 Expression and Efficiently Induces Apoptosis in MDM2-overexpressing Tumor Cells. Clin. Cancer Res. 5: 2242-2250 [Abstract] [Full Text]  
  • Giovanni, A., Wirtz-Brugger, F., Keramaris, E., Slack, R., Park, D. S. (1999). Involvement of Cell Cycle Elements, Cyclin-dependent Kinases, pRb, and E2F·DP, in B-amyloid-induced Neuronal Death. J. Biol. Chem. 274: 19011-19016 [Abstract] [Full Text]  
  • Macdonald, K., Bennett, M. R. (1999). cdc25A Is Necessary but Not Sufficient for Optimal c-myc–Induced Apoptosis and Cell Proliferation of Vascular Smooth Muscle Cells. Circ. Res. 84: 820-830 [Abstract] [Full Text]  
  • Gottifredi, V, Peschiaroli, A, Fimia, G., Maione, R (1999). p53-independent apoptosis induced by muscle differentiation stimuli in polyomavirus large T-expressing myoblasts. J. Cell Sci. 112: 2397-2407 [Abstract]  
  • Park, D. S., Morris, E. J., Padmanabhan, J., Shelanski, M. L., Geller, H. M., Greene, L. A. (1998). Cyclin-dependent Kinases Participate in Death of Neurons Evoked by DNA-damaging Agents. JCB 143: 457-467 [Abstract] [Full Text]  
  • Florio, M., Hernandez, M.-C., Yang, H., Shu, H.-K., Cleveland, J. L., Israel, M. A. (1998). Id2 Promotes Apoptosis by a Novel Mechanism Independent of Dimerization to Basic Helix-Loop-Helix Factors. Mol. Cell. Biol. 18: 5435-5444 [Abstract] [Full Text]  
  • Dyson, N. (1998). The regulation of E2F by pRB-family proteins. Genes Dev. 12: 2245-2262 [Full Text]  
  • Gopalkrishnan, R. V., Lam, E. W.-F., Kedinger, C. (1998). The p53 Tumor Suppressor Inhibits Transcription of the TATA-less Mouse DP1 Promoter. J. Biol. Chem. 273: 10972-10978 [Abstract] [Full Text]  
  • Bennett, M. R., Macdonald, K., Chan, S.-W., Boyle, J. J., Weissberg, P. L. (1998). Cooperative Interactions Between RB and p53 Regulate Cell Proliferation, Cell Senescence, and Apoptosis in Human Vascular Smooth Muscle Cells From Atherosclerotic Plaques. Circ. Res. 82: 704-712 [Abstract] [Full Text]  
  • Moore, P. S., Chang, Y. (1998). Kaposi's Sarcoma-Associated Herpesvirus-Encoded Oncogenes and Oncogenesis. J Natl Cancer Inst Monogr 1998: 65-71 [Abstract] [Full Text]  
  • Wing, B. A., Johnson, R. A., Huang, E.-S. (1998). Identification of Positive and Negative Regulatory Regions Involved in Regulating Expression of the Human Cytomegalovirus UL94 Late Promoter: Role of IE2-86 and Cellular p53 in Mediating Negative Regulatory Function. J. Virol. 72: 1814-1825 [Abstract] [Full Text]  
  • LeCouter, J., Kablar, B, Whyte, P., Ying, C, Rudnicki, M. (1998). Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene. Development 125: 4669-4679 [Abstract]  
  • Westendorf, J. J., Yamamoto, C. M., Lenny, N., Downing, J. R., Selsted, M. E., Hiebert, S. W. (1998). The t(8;21) Fusion Product, AML-1-ETO, Associates with C/EBP-alpha , Inhibits C/EBP-alpha -Dependent Transcription, and Blocks Granulocytic Differentiation. Mol. Cell. Biol. 18: 322-333 [Abstract] [Full Text]  
  • Royzman, I., Whittaker, A. J., Orr-Weaver, T. L. (1997). Mutations in Drosophila DP and E2F distinguish G1-S progression from an associated transcriptional program. Genes Dev. 11: 1999-2011 [Abstract] [Full Text]  
  • Hsieh, J K, Fredersdorf, S, Kouzarides, T, Martin, K, Lu, X (1997). E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction.. Genes Dev. 11: 1840-1852 [Abstract]  
  • Lundgren, K, Montes de Oca Luna, R, McNeill, Y B, Emerick, E P, Spencer, B, Barfield, C R, Lozano, G, Rosenberg, M P, Finlay, C A (1997). Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.. Genes Dev. 11: 714-725 [Abstract]  
  • Drissi, R., Zindy, F., Roussel, M. F., Cleveland, J. L. (2001). c-Myc-mediated Regulation of Telomerase Activity Is Disabled in Immortalized Cells. J. Biol. Chem. 276: 29994-30001 [Abstract] [Full Text]